| Austin C Gillette, | |
|
21 Winn Dr, Rexburg, ID 83440-5277 | |
| (208) 881-5222 | |
| (877) 441-4715 |
| Full Name | Austin C Gillette |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 21 Winn Dr, Rexburg, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083810287 | NPI | - | NPPES |
| 11243745 | Other | AAMC ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | M-10581 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health Of Eastern Idaho | Idaho falls, ID | Home health agency |
| Madison Memorial Hospital | Rexburg, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fall River Medical Pllc | 4981846698 | 6 |
News Archive
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
Researchers at the Perelman School of Medicine at the University of Pennsylvania have put sleeplessness on the map - literally. The research team, analyzing nationwide data collected by the Centers for Disease Control and Prevention (CDC), has produced the first state-by-state sleep maps for the United States, revealing that residents of Southern states suffer from the most sleep disturbances and daytime fatigue, while residents on the West Coast report the least amount of problems.
Medically treated patients with mild or no symptoms of gastroesophageal reflux disease (GERD) are at higher risk for developing esophageal cancer than those with severe GERD symptoms, according to a University of Pittsburgh study published in the current issue of Archives of Surgery.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on August 25, 2010 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 10,000 shares of common stock to two new employees.
› Verified 7 days ago
| Entity Name | Fall River Medical Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457698987 PECOS PAC ID: 4981846698 Enrollment ID: O20130808000831 |
News Archive
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
Researchers at the Perelman School of Medicine at the University of Pennsylvania have put sleeplessness on the map - literally. The research team, analyzing nationwide data collected by the Centers for Disease Control and Prevention (CDC), has produced the first state-by-state sleep maps for the United States, revealing that residents of Southern states suffer from the most sleep disturbances and daytime fatigue, while residents on the West Coast report the least amount of problems.
Medically treated patients with mild or no symptoms of gastroesophageal reflux disease (GERD) are at higher risk for developing esophageal cancer than those with severe GERD symptoms, according to a University of Pittsburgh study published in the current issue of Archives of Surgery.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on August 25, 2010 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 10,000 shares of common stock to two new employees.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Austin C Gillette, 21 Winn Dr, Rexburg, ID 83440-5277 Ph: (208) 881-5222 | Austin C Gillette, 21 Winn Dr, Rexburg, ID 83440-5277 Ph: (208) 881-5222 |
News Archive
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
Researchers at the Perelman School of Medicine at the University of Pennsylvania have put sleeplessness on the map - literally. The research team, analyzing nationwide data collected by the Centers for Disease Control and Prevention (CDC), has produced the first state-by-state sleep maps for the United States, revealing that residents of Southern states suffer from the most sleep disturbances and daytime fatigue, while residents on the West Coast report the least amount of problems.
Medically treated patients with mild or no symptoms of gastroesophageal reflux disease (GERD) are at higher risk for developing esophageal cancer than those with severe GERD symptoms, according to a University of Pittsburgh study published in the current issue of Archives of Surgery.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on August 25, 2010 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 10,000 shares of common stock to two new employees.
› Verified 7 days ago
Adriann J Wilcox, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 393 E 2nd N, Rexburg, ID 83440 Phone: 208-356-5401 Fax: 208-356-3111 | |
Corey T Rammell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 393 E 2nd N, Rexburg, ID 83440 Phone: 208-356-3691 | |
Kelly L Dustin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21 Winn Dr, Rexburg, ID 83440 Phone: 208-881-5222 Fax: 877-441-4715 | |
Michael Anderson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E Main St, Rexburg, ID 83440 Phone: 208-356-3691 | |
Brian Paul Beesley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 37 S 2nd E, Rexburg, ID 83440 Phone: 208-356-0234 Fax: 208-656-8444 | |
Gary R Sena, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 37 S 2nd E, Rexburg, ID 83440 Phone: 208-356-0234 |